OK Biotech Co Ltd
TWSE:4155
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
OK Biotech Co Ltd
Long-Term Debt
OK Biotech Co Ltd
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
OK Biotech Co Ltd
TWSE:4155
|
Long-Term Debt
NT$567m
|
CAGR 3-Years
14%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
M
|
Medtecs International Corporation Ltd
SGX:546
|
Long-Term Debt
$3.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Visco Vision Inc
TWSE:6782
|
Long-Term Debt
NT$324.5m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
P
|
Pegavision Corp
TWSE:6491
|
Long-Term Debt
NT$532.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
SciVision Biotech Inc
TWSE:1786
|
Long-Term Debt
NT$474.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
34%
|
|
OK Biotech Co Ltd
Glance View
OK Biotech Co. Ltd. engages in the manufacture, wholesale, trade, and retail of medical equipment and related homecare medical products. The company is headquartered in Hsinchu, Hsinchu. The company went IPO on 2010-12-30. The firm primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The firm distributes its products principally in Taiwan, other Asian markets and the United States.
See Also
What is OK Biotech Co Ltd's Long-Term Debt?
Long-Term Debt
567m
TWD
Based on the financial report for Sep 30, 2025, OK Biotech Co Ltd's Long-Term Debt amounts to 567m TWD.
What is OK Biotech Co Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
17%
Over the last year, the Long-Term Debt growth was 113%. The average annual Long-Term Debt growth rates for OK Biotech Co Ltd have been 14% over the past three years , 17% over the past five years .
